References
1. Ko, JK, Auyeung, KK. Inflammatory
bowel disease: etiology, pathogenesis and current therapy. Curr Pharm
Des 2014; 20,1082-96.https://www.doi.org/10.2174/13816128113199990416
2. Greuter, T, Vavricka, SR.
Extraintestinal manifestations in inflammatory bowel disease -
epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol
Hepatol 2019; 13,307-17.https://www.doi.org/10.1080/17474124.2019.1574569
3. Gajendran, M, Loganathan, P,
Catinella, AP, Hashash, JG. A comprehensive review and update on Crohn’s
disease. Dis Mon 2018; 64,20-57.https://www.doi.org/10.1016/j.disamonth.2017.07.001
4. Ordas, I, Eckmann, L, Talamini, M,
Baumgart, DC, Sandborn, WJ. Ulcerative colitis. Lancet 2012;
380,1606-19.https://www.doi.org/10.1016/s0140-6736(12)60150-0
5. Fiocchi, C. Inflammatory bowel
disease pathogenesis: where are we? J Gastroenterol Hepatol 2015; 30
Suppl 1,12-8.https://www.doi.org/10.1111/jgh.12751
6. Burisch, J, Jess, T, Martinato, M,
Lakatos, PL. The burden of inflammatory bowel disease in Europe. J
Crohns Colitis 2013; 7,322-37.https://www.doi.org/10.1016/j.crohns.2013.01.010
7. Zundler, S, Neurath, MF.
Immunopathogenesis of inflammatory bowel diseases: functional role of T
cells and T cell homing. Clin Exp Rheumatol 2015; 33,S19-28.
8. Wallace, KL, Zheng, LB, Kanazawa,
Y, Shih, DQ. Immunopathology of inflammatory bowel disease. World J
Gastroenterol 2014; 20,6-21.https://www.doi.org/10.3748/wjg.v20.i1.6
9. Park, HK, Kwak, MK, Kim, HJ, Ahima,
RS. Linking resistin, inflammation, and cardiometabolic diseases. Korean
J Intern Med 2017; 32,239-47.https://www.doi.org/10.3904/kjim.2016.229
10. Jamaluddin, MS, Weakley, SM, Yao,
Q, Chen, C. Resistin: functional roles and therapeutic considerations
for cardiovascular disease. Br J Pharmacol 2012; 165,622-32.https://www.doi.org/10.1111/j.1476-5381.2011.01369.x
11. Jung, HS, Park, KH, Cho, YM,
Chung, SS, Cho, HJ, Cho, SY, Kim, SJ, Kim, SY, Lee, HK, Park, KS.
Resistin is secreted from macrophages in atheromas and promotes
atherosclerosis. Cardiovasc Res 2006; 69,76-85.https://www.doi.org/10.1016/j.cardiores.2005.09.015
12. Karmiris, K, Koutroubakis, IE,
Kouroumalis, EA. Leptin, adiponectin, resistin, and
ghrelin–implications for inflammatory bowel disease. Mol Nutr Food
Res 2008; 52,855-66.https://www.doi.org/10.1002/mnfr.200700050
13. Trejo-Vazquez, F, Garza-Veloz, I,
Villela-Ramirez, GA, et al. Positive association between leptin serum
levels and disease activity on endoscopy in inflammatory bowel disease:
A case-control study. Exp Ther Med 2018; 15,3336-44.https://www.doi.org/10.3892/etm.2018.5835
14. Frivolt, K, Schwerd, T, Schatz,
SB, Freudenberg, F, Prell, C, Werkstetter, KJ, Bufler, P, Koletzko, S.
Hyperadiponectinemia During Infliximab Induction Therapy in Pediatric
Crohn Disease. J Pediatr Gastroenterol Nutr 2018; 66,915-9.https://www.doi.org/10.1097/mpg.0000000000001876
15. Theocharidou, E, Balaska, A,
Vogiatzis, K, Tellis, CC, Gossios, TD, Athyros, VG, Tselepis, AD,
Karagiannis, A. Hypertrophic Mesenteric Adipose Tissue May Play a Role
in Atherogenesis in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2016;
22,2206-12.https://www.doi.org/10.1097/mib.0000000000000873
16. Waluga, M, Hartleb, M, Boryczka,
G, Kukla, M, Zwirska-Korczala, K. Serum adipokines in inflammatory bowel
disease. World J Gastroenterol 2014; 20,6912-7.https://www.doi.org/10.3748/wjg.v20.i22.6912
17. Bostrom, EA, Ekstedt, M,
Kechagias, S, Sjowall, C, Bokarewa, MI, Almer, S. Resistin is associated
with breach of tolerance and anti-nuclear antibodies in patients with
hepatobiliary inflammation. Scand J Immunol 2011; 74,463-70.https://www.doi.org/10.1111/j.1365-3083.2011.02592.x
18. Kader, NA, El-Din, FA, Khatab,
EA, NE, EL. Does plasma resistin level have a role in predicting
inflammatory bowel disease activity? Indian J Gastroenterol 2010;
29,126-7.
19. Konrad, A, Lehrke, M,
Schachinger, V, Seibold, F, Stark, R, Ochsenkuhn, T, Parhofer, KG, Goke,
B, Broedl, UC. Resistin is an inflammatory marker of inflammatory bowel
disease in humans. Eur J Gastroenterol Hepatol 2007; 19,1070-4.https://www.doi.org/10.1097/MEG.0b013e3282f16251
20. Karmiris, K, Koutroubakis, IE,
Xidakis, C, Polychronaki, M, Voudouri, T, Kouroumalis, EA. Circulating
levels of leptin, adiponectin, resistin, and ghrelin in inflammatory
bowel disease. Inflamm Bowel Dis 2006; 12,100-5.https://www.doi.org/10.1097/01.mib.0000200345.38837.46
21. Abedimanesh, N, Motlagh, B,
Abedimanesh, S, Ostadrahimi, A, Somi, MH, Jafarabad, MA, Rezazadeb, M.
Circulating resistin in ulcerative colitis, relation with
anthropometric, body composition and inflammatory parameters. Progress
in Nutrition 2018; 20,132-6.https://www.doi.org/10.23751/pn.v20i2-S.6560
22. Tan, K. The relationship between
serum Levels of Resistin, YKL-40 and uIcerative colitis. University of
south China 2012.
23. Stroup, DF, Berlin, JA, Morton,
SC, Olkin, I, Williamson, GD, Rennie, D, Moher, D, Becker, BJ, Sipe, TA,
Thacker, SB. Meta-analysis of observational studies in epidemiology: a
proposal for reporting. Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group. Jama 2000; 283,2008-12.https://www.doi.org/10.1001/jama.283.15.2008
24. Hozo, SP, Djulbegovic, B, Hozo,
I. Estimating the mean and variance from the median, range, and the size
of a sample. BMC Med Res Methodol 2005; 5,13.https://www.doi.org/10.1186/1471-2288-5-13
25. Silswal, N, Singh, AK, Aruna, B,
Mukhopadhyay, S, Ghosh, S, Ehtesham, NZ. Human resistin stimulates the
pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by
NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005;
334,1092-101.https://www.doi.org/10.1016/j.bbrc.2005.06.202
26. Kyriakou, A, Patsatsi, A,
Sotiriadis, D, Goulis, DG. Serum Leptin, Resistin, and Adiponectin
Concentrations in Psoriasis: A Meta-Analysis of Observational Studies.
Dermatology 2017; 233,378-89.https://www.doi.org/10.1159/000481882
27. Yang, J, Zhang, X, Ma, Y, et al.
Serum levels of leptin, adiponectin and resistin in patients with
ankylosing spondylitis: A systematic review and meta-analysis. Int
Immunopharmacol 2017; 52,310-7.https://www.doi.org/10.1016/j.intimp.2017.09.029
28. Huang, Q, Tao, SS, Zhang, YJ, et
al. Serum resistin levels in patients with rheumatoid arthritis and
systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 2015;
34,1713-20.https://www.doi.org/10.1007/s10067-015-2955-5
29. Hutcheson, J. Adipokines
influence the inflammatory balance in autoimmunity. Cytokine 2015;
75,272-9.https://www.doi.org/10.1016/j.cyto.2015.04.004
30. Tsiotra, PC, Boutati, E,
Dimitriadis, G, Raptis, SA. High insulin and leptin increase resistin
and inflammatory cytokine production from human mononuclear cells.
Biomed Res Int 2013; 2013,487081.https://www.doi.org/10.1155/2013/487081
31. Acquarone, E, Monacelli, F,
Borghi, R, Nencioni, A, Odetti, P. Resistin: A reappraisal. Mech Ageing
Dev 2019; 178,46-63.https://www.doi.org/10.1016/j.mad.2019.01.004
32. Torres, J, Mehandru, S, Colombel,
JF, Peyrin-Biroulet, L. Crohn’s disease. Lancet 2017; 389,1741-55.https://www.doi.org/10.1016/s0140-6736(16)31711-1
33. Adams, SM, Bornemann, PH.
Ulcerative colitis. Am Fam Physician 2013; 87,699-705.
34. Schaffler, A, Scholmerich, J,
Buchler, C. Mechanisms of disease: adipocytokines and visceral adipose
tissue–emerging role in intestinal and mesenteric diseases. Nat Clin
Pract Gastroenterol Hepatol 2005; 2,103-11.https://www.doi.org/10.1038/ncpgasthep0090
35. Kreuter, R, Wankell, M,
Ahlenstiel, G, Hebbard, L. The role of obesity in inflammatory bowel
disease. Biochim Biophys Acta Mol Basis Dis 2019; 1865,63-72.https://www.doi.org/10.1016/j.bbadis.2018.10.020